Understanding Personalized Medicine for Myeloma

https://vimeo.com/779453431 Myeloma experts Dr. Omar Nadeem and Dr. Betsy O’Donnell discuss the personalized approach to treating myeloma and the factors that are considered when making care decisions. Dr. Omar Nadeem…

How Is MGUS Monitored?

https://vimeo.com/779453510 Myeloma expert Dr. Irene Ghobrial discusses how patients with monoclonal gammopathy of undetermined significance (MGUS) are monitored over time and shares an update on research being conducted to learn…

What Should Patients Know About Myeloma Testing?

https://vimeo.com/779453701 Testing following a myeloma diagnosis, or relapse, can impact care and treatment decisions. Drs. Betsy O’Donnell and Omar Nadeem provide an overview of essential myeloma testing, how the test…

Understanding MGUS & Smoldering Myeloma: What’s the Difference?

https://vimeo.com/779453854 Myeloma expert Dr. Irene Ghobrial explains the difference between the precursor conditions, MGUS (monocloncal gammopathy of undetermined significance) and smoldering myeloma, including how these conditions are detected. Dr. Irene…

Advances in Myeloma Molecular Testing

https://vimeo.com/764346574 What is molecular testing, and how does it impact myeloma care? Dr. Abdullah Khan from the Ohio State University Comprehensive Cancer Center – The James discusses the specific markers…

How Do Test Results Impact Myeloma Treatment Options?

https://vimeo.com/755523666 Myeloma expert Dr. Melissa Alsina reviews the test results that are taken into consideration when choosing a treatment approach for patients. Dr. Melissa Alsina is an associate professor of…

How Should MGUS Be Monitored Over Time?

https://vimeo.com/652660490 Myeloma expert, Dr. Saad Usmani, discusses the diagnosis of monoclonal gammopathy of undetermined significance (MGUS) and how patients are monitored, including key lab values that should be followed. Dr….

Share On:

Facebook
Twitter
LinkedIn